Efficacy of single and multiple oral doses of fosfomycin against Pseudomonas aeruginosa urinary tract infections in a dynamic in vitro bladder infection model
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy of single and multiple oral doses of fosfomycin against Pseudomonas aeruginosa urinary tract infections in a dynamic in vitro bladder infection model
Authors
Keywords
-
Journal
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2020-03-13
DOI
10.1093/jac/dkaa127
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Small molecule inhibitor of FosA expands fosfomycin activity to multidrug-resistant Gram-negative pathogens
- (2019) Adam D. Tomich et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ceftazidime-Avibactam in Combination With Fosfomycin: A Novel Therapeutic Strategy Against Multidrug-Resistant Pseudomonas aeruginosa
- (2019) Krisztina M Papp-Wallace et al. JOURNAL OF INFECTIOUS DISEASES
- Prevalence of in vitro synergistic antibiotic interaction between fosfomycin and nonsusceptible antimicrobials in carbapenem-resistant Pseudomonas aeruginosa
- (2019) Lindsay M. Avery et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Phase I Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Two Dosing Regimens of Oral Fosfomycin Tromethamine in Healthy Adult Participants (PROOF)
- (2018) E Wenzler et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Determination of the Dynamically Linked Indices of Fosfomycin for Pseudomonas aeruginosa in the Hollow Fiber Infection Model
- (2018) Arnold Louie et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- High interindividual variability in urinary fosfomycin concentrations in healthy female volunteers
- (2018) R.A. Wijma et al. CLINICAL MICROBIOLOGY AND INFECTION
- Elucidation of the pharmacokinetic/pharmacodynamic determinants of fosfomycin activity against Pseudomonas aeruginosa using a dynamic in vitro model
- (2018) Hajira Bilal et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The combination of fosfomycin plus meropenem is synergistic for Pseudomonas aeruginosa PA01 in a Hollow Fiber Infection Model (HFIM).
- (2018) G.L. Drusano et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Fosfomycin efficacy and emergence of resistance among Enterobacteriaceae in an in vitro dynamic bladder infection model
- (2017) Iain J Abbott et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- A fast and sensitive LC–MS/MS method for the quantification of fosfomycin in human urine and plasma using one sample preparation method and HILIC chromatography
- (2017) Rixt A. Wijma et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- The N -Acetylmuramic Acid 6-Phosphate Phosphatase MupP Completes the Pseudomonas Peptidoglycan Recycling Pathway Leading to Intrinsic Fosfomycin Resistance
- (2017) Marina Borisova et al. mBio
- Widespread Fosfomycin Resistance in Gram-Negative Bacteria Attributable to the Chromosomal fosA Gene
- (2017) Ryota Ito et al. mBio
- Efficacy and Safety of Oral Fosfomycin for Urinary Tract Infections in Hospitalized Patients
- (2016) Shauna Jacobson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Assessment of Fosfomycin for Complicated or Multidrug-Resistant Urinary Tract Infections: Patient Characteristics and Outcomes
- (2016) Stephanie E. Giancola et al. CHEMOTHERAPY
- Clinical Management of an Increasing Threat: Outpatient Urinary Tract Infections Due to Multidrug-Resistant Uropathogens: Table 1.
- (2016) Emily Walker et al. CLINICAL INFECTIOUS DISEASES
- Fosfomycin
- (2016) Matthew E. Falagas et al. CLINICAL MICROBIOLOGY REVIEWS
- Global epidemiology of urinary tract infections
- (2016) Zafer Tandogdu et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Clinically relevant concentrations of fosfomycin combined with polymyxin B, tobramycin or ciprofloxacin enhance bacterial killing ofPseudomonas aeruginosa, but do not suppress the emergence of fosfomycin resistance
- (2016) Clare C. Walsh et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Synergistic activity of fosfomycin, β-lactams and peptidoglycan recycling inhibition againstPseudomonas aeruginosa
- (2016) Myriam Hamou-Segarra et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Evaluation of the in vitro growth of urinary tract infection-causing gram-negative and gram-positive bacteria in a proposed synthetic human urine (SHU) medium
- (2016) Deepak S. Ipe et al. JOURNAL OF MICROBIOLOGICAL METHODS
- Antimicrobial Activity of Fosfomycin-Tobramycin Combination against Pseudomonas aeruginosa Isolates Assessed by Time-Kill Assays and Mutant Prevention Concentrations
- (2015) María Díez-Aguilar et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacodynamics of Ceftazidime and Avibactam in Neutropenic Mice with Thigh or Lung Infection
- (2015) Johanna Berkhout et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of fosfomycin and comparison of several susceptibility testing methods against contemporary urine isolates
- (2015) Elizabeth B. Hirsch et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- In vitropharmacodynamics of fosfomycin against clinical isolates ofPseudomonas aeruginosa
- (2015) Clare C. Walsh et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Urinary tract infections: epidemiology, mechanisms of infection and treatment options
- (2015) Ana L. Flores-Mireles et al. NATURE REVIEWS MICROBIOLOGY
- The emerging threat of multidrug-resistant Gram-negative bacteria in urology
- (2015) Hosam M. Zowawi et al. Nature Reviews Urology
- Pseudomonas aeruginosa: Evolution of Antimicrobial Resistance and Implications for Therapy
- (2015) Kate McCarthy SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- Blocking Peptidoglycan Recycling in Pseudomonas aeruginosa Attenuates Intrinsic Resistance to Fosfomycin
- (2014) Marina Borisova et al. Microbial Drug Resistance
- In VitroActivity of Fosfomycin against a Collection of Clinical Pseudomonas aeruginosa Isolates from 16 Spanish Hospitals: Establishing the Validity of Standard Broth Microdilution as Susceptibility Testing Method
- (2013) María Díez-Aguilar et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Experience with Fosfomycin for Treatment of Urinary Tract Infections Due to Multidrug-Resistant Organisms
- (2012) Elizabeth A. Neuner et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- ‘Old’ antibiotics for emerging multidrug-resistant bacteria
- (2012) Phillip J. Bergen et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Antimicrobial Susceptibilities of Commonly Encountered Bacterial Isolates to Fosfomycin Determined by Agar Dilution and Disk Diffusion Methods
- (2011) Ching-Lan Lu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Synergy of fosfomycin with carbapenems, colistin, netilmicin, and tigecycline against multidrug-resistant Klebsiella pneumoniae, Escherichia coli, and Pseudomonas aeruginosa clinical isolates
- (2011) G. Samonis et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of fosfomycin for the treatment of patients with systemic infections
- (2009) Nikos Roussos et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- The Glycerol-3-Phosphate Permease GlpT Is the Only Fosfomycin Transporter in Pseudomonas aeruginosa
- (2009) A. Castaneda-Garcia et al. JOURNAL OF BACTERIOLOGY
- Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum β-lactamase producing, Enterobacteriaceae infections: a systematic review
- (2009) Matthew E Falagas et al. LANCET INFECTIOUS DISEASES
- Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances
- (2008) Irith Wiegand et al. Nature Protocols
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started